nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0995	0.279	CbGbCtD
Amantadine—ABCB1—Betamethasone—psoriatic arthritis	0.0647	0.182	CbGbCtD
Amantadine—ABCB1—Prednisolone—psoriatic arthritis	0.0638	0.179	CbGbCtD
Amantadine—ABCB1—Prednisone—psoriatic arthritis	0.0603	0.169	CbGbCtD
Amantadine—ABCB1—Dexamethasone—psoriatic arthritis	0.0376	0.106	CbGbCtD
Amantadine—ABCB1—Methotrexate—psoriatic arthritis	0.0302	0.0849	CbGbCtD
Amantadine—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00233	0.00362	CcSEcCtD
Amantadine—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00233	0.00362	CcSEcCtD
Amantadine—Sweating increased—Triamcinolone—psoriatic arthritis	0.00227	0.00353	CcSEcCtD
Amantadine—Amnesia—Prednisone—psoriatic arthritis	0.00227	0.00353	CcSEcCtD
Amantadine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00227	0.00352	CcSEcCtD
Amantadine—Coma—Methotrexate—psoriatic arthritis	0.00224	0.00348	CcSEcCtD
Amantadine—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00219	0.00339	CcSEcCtD
Amantadine—Cardiac failure—Prednisone—psoriatic arthritis	0.00219	0.00339	CcSEcCtD
Amantadine—Lethargy—Prednisone—psoriatic arthritis	0.00218	0.00338	CcSEcCtD
Amantadine—Osteoarthritis—Prednisone—psoriatic arthritis	0.00213	0.00331	CcSEcCtD
Amantadine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00208	0.00324	CcSEcCtD
Amantadine—Sweating increased—Dexamethasone—psoriatic arthritis	0.00206	0.0032	CcSEcCtD
Amantadine—Sweating increased—Betamethasone—psoriatic arthritis	0.00206	0.0032	CcSEcCtD
Amantadine—Irritability—Prednisone—psoriatic arthritis	0.00204	0.00316	CcSEcCtD
Amantadine—Photosensitivity—Methotrexate—psoriatic arthritis	0.00203	0.00315	CcSEcCtD
Amantadine—Cardiac arrest—Prednisone—psoriatic arthritis	0.00203	0.00315	CcSEcCtD
Amantadine—Visual impairment—Prednisolone—psoriatic arthritis	0.00196	0.00304	CcSEcCtD
Amantadine—Renal failure acute—Methotrexate—psoriatic arthritis	0.00193	0.003	CcSEcCtD
Amantadine—Visual disturbance—Methotrexate—psoriatic arthritis	0.00188	0.00292	CcSEcCtD
Amantadine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00185	0.00288	CcSEcCtD
Amantadine—Lethargy—Methotrexate—psoriatic arthritis	0.00182	0.00283	CcSEcCtD
Amantadine—Arrhythmia—Prednisolone—psoriatic arthritis	0.00181	0.00282	CcSEcCtD
Amantadine—Sweating increased—Prednisone—psoriatic arthritis	0.0018	0.00279	CcSEcCtD
Amantadine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.0018	0.00279	CcSEcCtD
Amantadine—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00178	0.00277	CcSEcCtD
Amantadine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00174	0.0027	CcSEcCtD
Amantadine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00173	0.00269	CcSEcCtD
Amantadine—Neutropenia—Prednisone—psoriatic arthritis	0.00172	0.00268	CcSEcCtD
Amantadine—Irritability—Methotrexate—psoriatic arthritis	0.0017	0.00264	CcSEcCtD
Amantadine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00169	0.00263	CcSEcCtD
Amantadine—Hallucination—Dexamethasone—psoriatic arthritis	0.00169	0.00262	CcSEcCtD
Amantadine—Hallucination—Betamethasone—psoriatic arthritis	0.00169	0.00262	CcSEcCtD
Amantadine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00168	0.00261	CcSEcCtD
Amantadine—Ataxia—Methotrexate—psoriatic arthritis	0.00168	0.0026	CcSEcCtD
Amantadine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00167	0.00259	CcSEcCtD
Amantadine—Vision blurred—Prednisolone—psoriatic arthritis	0.00167	0.00259	CcSEcCtD
Amantadine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00166	0.00259	CcSEcCtD
Amantadine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00165	0.00256	CcSEcCtD
Amantadine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00163	0.00254	CcSEcCtD
Amantadine—Visual impairment—Betamethasone—psoriatic arthritis	0.00163	0.00254	CcSEcCtD
Amantadine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00163	0.00254	CcSEcCtD
Amantadine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00162	0.00252	CcSEcCtD
Amantadine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00158	0.00246	CcSEcCtD
Amantadine—Eye disorder—Betamethasone—psoriatic arthritis	0.00158	0.00246	CcSEcCtD
Amantadine—Angiopathy—Betamethasone—psoriatic arthritis	0.00154	0.00239	CcSEcCtD
Amantadine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00154	0.00239	CcSEcCtD
Amantadine—Convulsion—Prednisolone—psoriatic arthritis	0.00153	0.00238	CcSEcCtD
Amantadine—Hypertension—Prednisolone—psoriatic arthritis	0.00153	0.00237	CcSEcCtD
Amantadine—Arrhythmia—Betamethasone—psoriatic arthritis	0.00151	0.00235	CcSEcCtD
Amantadine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00151	0.00235	CcSEcCtD
Amantadine—Alopecia—Dexamethasone—psoriatic arthritis	0.0015	0.00233	CcSEcCtD
Amantadine—Alopecia—Betamethasone—psoriatic arthritis	0.0015	0.00233	CcSEcCtD
Amantadine—Hallucination—Prednisone—psoriatic arthritis	0.00147	0.00228	CcSEcCtD
Amantadine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00144	0.00224	CcSEcCtD
Amantadine—Oedema—Prednisolone—psoriatic arthritis	0.00144	0.00224	CcSEcCtD
Amantadine—Neutropenia—Methotrexate—psoriatic arthritis	0.00144	0.00224	CcSEcCtD
Amantadine—Convulsion—Triamcinolone—psoriatic arthritis	0.00141	0.00219	CcSEcCtD
Amantadine—Tachycardia—Prednisolone—psoriatic arthritis	0.00141	0.00219	CcSEcCtD
Amantadine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00141	0.00218	CcSEcCtD
Amantadine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00141	0.00218	CcSEcCtD
Amantadine—Hypertension—Triamcinolone—psoriatic arthritis	0.0014	0.00218	CcSEcCtD
Amantadine—Hypertension—Methylprednisolone—psoriatic arthritis	0.0014	0.00217	CcSEcCtD
Amantadine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00139	0.00217	CcSEcCtD
Amantadine—Eye disorder—Prednisone—psoriatic arthritis	0.00138	0.00214	CcSEcCtD
Amantadine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00138	0.00214	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00137	0.00213	CcSEcCtD
Amantadine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00135	0.0021	CcSEcCtD
Amantadine—Angiopathy—Prednisone—psoriatic arthritis	0.00134	0.00208	CcSEcCtD
Amantadine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00133	0.00207	CcSEcCtD
Amantadine—Oedema—Triamcinolone—psoriatic arthritis	0.00133	0.00206	CcSEcCtD
Amantadine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00133	0.00206	CcSEcCtD
Amantadine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00132	0.00206	CcSEcCtD
Amantadine—Arrhythmia—Prednisone—psoriatic arthritis	0.00132	0.00205	CcSEcCtD
Amantadine—Insomnia—Prednisolone—psoriatic arthritis	0.0013	0.00203	CcSEcCtD
Amantadine—Alopecia—Prednisone—psoriatic arthritis	0.0013	0.00203	CcSEcCtD
Amantadine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0013	0.00202	CcSEcCtD
Amantadine—Paraesthesia—Prednisolone—psoriatic arthritis	0.0013	0.00201	CcSEcCtD
Amantadine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00129	0.00201	CcSEcCtD
Amantadine—Mental disorder—Prednisone—psoriatic arthritis	0.00129	0.00201	CcSEcCtD
Amantadine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00129	0.00201	CcSEcCtD
Amantadine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00129	0.002	CcSEcCtD
Amantadine—Malnutrition—Prednisone—psoriatic arthritis	0.00128	0.00199	CcSEcCtD
Amantadine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00128	0.00199	CcSEcCtD
Amantadine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00128	0.00199	CcSEcCtD
Amantadine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00128	0.00199	CcSEcCtD
Amantadine—Convulsion—Dexamethasone—psoriatic arthritis	0.00128	0.00198	CcSEcCtD
Amantadine—Convulsion—Betamethasone—psoriatic arthritis	0.00128	0.00198	CcSEcCtD
Amantadine—Hypertension—Betamethasone—psoriatic arthritis	0.00127	0.00198	CcSEcCtD
Amantadine—Hypertension—Dexamethasone—psoriatic arthritis	0.00127	0.00198	CcSEcCtD
Amantadine—Anxiety—Betamethasone—psoriatic arthritis	0.00125	0.00194	CcSEcCtD
Amantadine—Anxiety—Dexamethasone—psoriatic arthritis	0.00125	0.00194	CcSEcCtD
Amantadine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00124	0.00192	CcSEcCtD
Amantadine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00122	0.00189	CcSEcCtD
Amantadine—Vision blurred—Prednisone—psoriatic arthritis	0.00121	0.00188	CcSEcCtD
Amantadine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00121	0.00188	CcSEcCtD
Amantadine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0012	0.00187	CcSEcCtD
Amantadine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0012	0.00187	CcSEcCtD
Amantadine—Oedema—Dexamethasone—psoriatic arthritis	0.0012	0.00187	CcSEcCtD
Amantadine—Oedema—Betamethasone—psoriatic arthritis	0.0012	0.00187	CcSEcCtD
Amantadine—Insomnia—Triamcinolone—psoriatic arthritis	0.0012	0.00186	CcSEcCtD
Amantadine—Insomnia—Methylprednisolone—psoriatic arthritis	0.0012	0.00186	CcSEcCtD
Amantadine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00119	0.00185	CcSEcCtD
Amantadine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00119	0.00185	CcSEcCtD
Amantadine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00119	0.00185	CcSEcCtD
Amantadine—Visual impairment—Methotrexate—psoriatic arthritis	0.00119	0.00185	CcSEcCtD
Amantadine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00118	0.00184	CcSEcCtD
Amantadine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00118	0.00183	CcSEcCtD
Amantadine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00118	0.00183	CcSEcCtD
Amantadine—Agitation—Prednisone—psoriatic arthritis	0.00118	0.00183	CcSEcCtD
Amantadine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00117	0.00182	CcSEcCtD
Amantadine—Tachycardia—Betamethasone—psoriatic arthritis	0.00117	0.00182	CcSEcCtD
Amantadine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00117	0.00181	CcSEcCtD
Amantadine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00117	0.00181	CcSEcCtD
Amantadine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00116	0.00181	CcSEcCtD
Amantadine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00116	0.00181	CcSEcCtD
Amantadine—Eye disorder—Methotrexate—psoriatic arthritis	0.00115	0.00179	CcSEcCtD
Amantadine—Anorexia—Betamethasone—psoriatic arthritis	0.00115	0.00178	CcSEcCtD
Amantadine—Anorexia—Dexamethasone—psoriatic arthritis	0.00115	0.00178	CcSEcCtD
Amantadine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00114	0.00178	CcSEcCtD
Amantadine—Fatigue—Triamcinolone—psoriatic arthritis	0.00114	0.00178	CcSEcCtD
Amantadine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00114	0.00177	CcSEcCtD
Amantadine—Hypotension—Betamethasone—psoriatic arthritis	0.00112	0.00175	CcSEcCtD
Amantadine—Hypotension—Dexamethasone—psoriatic arthritis	0.00112	0.00175	CcSEcCtD
Amantadine—Angiopathy—Methotrexate—psoriatic arthritis	0.00112	0.00174	CcSEcCtD
Amantadine—Convulsion—Prednisone—psoriatic arthritis	0.00111	0.00173	CcSEcCtD
Amantadine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00111	0.00173	CcSEcCtD
Amantadine—Hypertension—Prednisone—psoriatic arthritis	0.00111	0.00172	CcSEcCtD
Amantadine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00109	0.0017	CcSEcCtD
Amantadine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00109	0.00169	CcSEcCtD
Amantadine—Anxiety—Prednisone—psoriatic arthritis	0.00109	0.00169	CcSEcCtD
Amantadine—Alopecia—Methotrexate—psoriatic arthritis	0.00109	0.00169	CcSEcCtD
Amantadine—Insomnia—Betamethasone—psoriatic arthritis	0.00109	0.00169	CcSEcCtD
Amantadine—Insomnia—Dexamethasone—psoriatic arthritis	0.00109	0.00169	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00109	0.00169	CcSEcCtD
Amantadine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00108	0.00168	CcSEcCtD
Amantadine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00108	0.00168	CcSEcCtD
Amantadine—Mental disorder—Methotrexate—psoriatic arthritis	0.00108	0.00168	CcSEcCtD
Amantadine—Malnutrition—Methotrexate—psoriatic arthritis	0.00107	0.00167	CcSEcCtD
Amantadine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00106	0.00165	CcSEcCtD
Amantadine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00106	0.00165	CcSEcCtD
Amantadine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00106	0.00165	CcSEcCtD
Amantadine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00105	0.00163	CcSEcCtD
Amantadine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00105	0.00163	CcSEcCtD
Amantadine—Oedema—Prednisone—psoriatic arthritis	0.00105	0.00163	CcSEcCtD
Amantadine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00105	0.00163	CcSEcCtD
Amantadine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00105	0.00163	CcSEcCtD
Amantadine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Amantadine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Amantadine—Fatigue—Dexamethasone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Amantadine—Fatigue—Betamethasone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Amantadine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00103	0.0016	CcSEcCtD
Amantadine—Tachycardia—Prednisone—psoriatic arthritis	0.00102	0.00159	CcSEcCtD
Amantadine—Skin disorder—Prednisone—psoriatic arthritis	0.00102	0.00158	CcSEcCtD
Amantadine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00101	0.00157	CcSEcCtD
Amantadine—Vision blurred—Methotrexate—psoriatic arthritis	0.00101	0.00157	CcSEcCtD
Amantadine—Anorexia—Prednisone—psoriatic arthritis	0.000999	0.00155	CcSEcCtD
Amantadine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000992	0.00154	CcSEcCtD
Amantadine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000992	0.00154	CcSEcCtD
Amantadine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000977	0.00152	CcSEcCtD
Amantadine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000975	0.00151	CcSEcCtD
Amantadine—Leukopenia—Methotrexate—psoriatic arthritis	0.000961	0.00149	CcSEcCtD
Amantadine—Dizziness—Prednisolone—psoriatic arthritis	0.000954	0.00148	CcSEcCtD
Amantadine—Asthenia—Triamcinolone—psoriatic arthritis	0.000952	0.00148	CcSEcCtD
Amantadine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000952	0.00148	CcSEcCtD
Amantadine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000952	0.00148	CcSEcCtD
Amantadine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00095	0.00148	CcSEcCtD
Amantadine—Insomnia—Prednisone—psoriatic arthritis	0.000948	0.00147	CcSEcCtD
Amantadine—Paraesthesia—Prednisone—psoriatic arthritis	0.000941	0.00146	CcSEcCtD
Amantadine—Pruritus—Triamcinolone—psoriatic arthritis	0.000939	0.00146	CcSEcCtD
Amantadine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000936	0.00145	CcSEcCtD
Amantadine—Convulsion—Methotrexate—psoriatic arthritis	0.00093	0.00144	CcSEcCtD
Amantadine—Dyspepsia—Prednisone—psoriatic arthritis	0.000923	0.00143	CcSEcCtD
Amantadine—Decreased appetite—Prednisone—psoriatic arthritis	0.000911	0.00142	CcSEcCtD
Amantadine—Rash—Prednisolone—psoriatic arthritis	0.00091	0.00141	CcSEcCtD
Amantadine—Dermatitis—Prednisolone—psoriatic arthritis	0.000909	0.00141	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000908	0.00141	CcSEcCtD
Amantadine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000906	0.00141	CcSEcCtD
Amantadine—Fatigue—Prednisone—psoriatic arthritis	0.000904	0.0014	CcSEcCtD
Amantadine—Headache—Prednisolone—psoriatic arthritis	0.000904	0.0014	CcSEcCtD
Amantadine—Constipation—Prednisone—psoriatic arthritis	0.000896	0.00139	CcSEcCtD
Amantadine—Confusional state—Methotrexate—psoriatic arthritis	0.000883	0.00137	CcSEcCtD
Amantadine—Dizziness—Triamcinolone—psoriatic arthritis	0.000877	0.00136	CcSEcCtD
Amantadine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000876	0.00136	CcSEcCtD
Amantadine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000875	0.00136	CcSEcCtD
Amantadine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000864	0.00134	CcSEcCtD
Amantadine—Asthenia—Dexamethasone—psoriatic arthritis	0.000864	0.00134	CcSEcCtD
Amantadine—Asthenia—Betamethasone—psoriatic arthritis	0.000864	0.00134	CcSEcCtD
Amantadine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000859	0.00133	CcSEcCtD
Amantadine—Nausea—Prednisolone—psoriatic arthritis	0.000857	0.00133	CcSEcCtD
Amantadine—Pruritus—Betamethasone—psoriatic arthritis	0.000852	0.00132	CcSEcCtD
Amantadine—Pruritus—Dexamethasone—psoriatic arthritis	0.000852	0.00132	CcSEcCtD
Amantadine—Skin disorder—Methotrexate—psoriatic arthritis	0.000851	0.00132	CcSEcCtD
Amantadine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000847	0.00132	CcSEcCtD
Amantadine—Vomiting—Triamcinolone—psoriatic arthritis	0.000843	0.00131	CcSEcCtD
Amantadine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000842	0.00131	CcSEcCtD
Amantadine—Rash—Triamcinolone—psoriatic arthritis	0.000836	0.0013	CcSEcCtD
Amantadine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000836	0.0013	CcSEcCtD
Amantadine—Anorexia—Methotrexate—psoriatic arthritis	0.000835	0.0013	CcSEcCtD
Amantadine—Rash—Methylprednisolone—psoriatic arthritis	0.000835	0.0013	CcSEcCtD
Amantadine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000834	0.0013	CcSEcCtD
Amantadine—Headache—Triamcinolone—psoriatic arthritis	0.000831	0.00129	CcSEcCtD
Amantadine—Headache—Methylprednisolone—psoriatic arthritis	0.000829	0.00129	CcSEcCtD
Amantadine—Body temperature increased—Prednisone—psoriatic arthritis	0.000829	0.00129	CcSEcCtD
Amantadine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000824	0.00128	CcSEcCtD
Amantadine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000824	0.00128	CcSEcCtD
Amantadine—Hypotension—Methotrexate—psoriatic arthritis	0.000819	0.00127	CcSEcCtD
Amantadine—Dizziness—Betamethasone—psoriatic arthritis	0.000796	0.00124	CcSEcCtD
Amantadine—Dizziness—Dexamethasone—psoriatic arthritis	0.000796	0.00124	CcSEcCtD
Amantadine—Insomnia—Methotrexate—psoriatic arthritis	0.000792	0.00123	CcSEcCtD
Amantadine—Nausea—Triamcinolone—psoriatic arthritis	0.000788	0.00122	CcSEcCtD
Amantadine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000787	0.00122	CcSEcCtD
Amantadine—Nausea—Methylprednisolone—psoriatic arthritis	0.000786	0.00122	CcSEcCtD
Amantadine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000781	0.00121	CcSEcCtD
Amantadine—Somnolence—Methotrexate—psoriatic arthritis	0.000779	0.00121	CcSEcCtD
Amantadine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000772	0.0012	CcSEcCtD
Amantadine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000771	0.0012	CcSEcCtD
Amantadine—Vomiting—Betamethasone—psoriatic arthritis	0.000765	0.00119	CcSEcCtD
Amantadine—Vomiting—Dexamethasone—psoriatic arthritis	0.000765	0.00119	CcSEcCtD
Amantadine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000762	0.00118	CcSEcCtD
Amantadine—Rash—Dexamethasone—psoriatic arthritis	0.000759	0.00118	CcSEcCtD
Amantadine—Rash—Betamethasone—psoriatic arthritis	0.000759	0.00118	CcSEcCtD
Amantadine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000758	0.00118	CcSEcCtD
Amantadine—Dermatitis—Betamethasone—psoriatic arthritis	0.000758	0.00118	CcSEcCtD
Amantadine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000756	0.00117	CcSEcCtD
Amantadine—Fatigue—Methotrexate—psoriatic arthritis	0.000755	0.00117	CcSEcCtD
Amantadine—Headache—Betamethasone—psoriatic arthritis	0.000754	0.00117	CcSEcCtD
Amantadine—Headache—Dexamethasone—psoriatic arthritis	0.000754	0.00117	CcSEcCtD
Amantadine—Asthenia—Prednisone—psoriatic arthritis	0.000752	0.00117	CcSEcCtD
Amantadine—Pruritus—Prednisone—psoriatic arthritis	0.000742	0.00115	CcSEcCtD
Amantadine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000722	0.00112	CcSEcCtD
Amantadine—Diarrhoea—Prednisone—psoriatic arthritis	0.000717	0.00111	CcSEcCtD
Amantadine—Nausea—Betamethasone—psoriatic arthritis	0.000715	0.00111	CcSEcCtD
Amantadine—Nausea—Dexamethasone—psoriatic arthritis	0.000715	0.00111	CcSEcCtD
Amantadine—Dizziness—Prednisone—psoriatic arthritis	0.000693	0.00108	CcSEcCtD
Amantadine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000693	0.00108	CcSEcCtD
Amantadine—Vomiting—Prednisone—psoriatic arthritis	0.000666	0.00104	CcSEcCtD
Amantadine—Rash—Prednisone—psoriatic arthritis	0.000661	0.00103	CcSEcCtD
Amantadine—Dermatitis—Prednisone—psoriatic arthritis	0.00066	0.00103	CcSEcCtD
Amantadine—Headache—Prednisone—psoriatic arthritis	0.000657	0.00102	CcSEcCtD
Amantadine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000645	0.001	CcSEcCtD
Amantadine—Asthenia—Methotrexate—psoriatic arthritis	0.000629	0.000976	CcSEcCtD
Amantadine—Nausea—Prednisone—psoriatic arthritis	0.000623	0.000967	CcSEcCtD
Amantadine—Pruritus—Methotrexate—psoriatic arthritis	0.00062	0.000963	CcSEcCtD
Amantadine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000599	0.000931	CcSEcCtD
Amantadine—Dizziness—Methotrexate—psoriatic arthritis	0.000579	0.0009	CcSEcCtD
Amantadine—Vomiting—Methotrexate—psoriatic arthritis	0.000557	0.000865	CcSEcCtD
Amantadine—Rash—Methotrexate—psoriatic arthritis	0.000552	0.000858	CcSEcCtD
Amantadine—Dermatitis—Methotrexate—psoriatic arthritis	0.000552	0.000857	CcSEcCtD
Amantadine—Headache—Methotrexate—psoriatic arthritis	0.000549	0.000852	CcSEcCtD
Amantadine—Nausea—Methotrexate—psoriatic arthritis	0.00052	0.000808	CcSEcCtD
